Cox B-IN-1

Cox B-IN-1 (7a) exhibits antiviral activity against Coxsackievirus B (Cox B) . Cox B-IN-1 (7a) possesses dual activity that inhibits viral adsorption and replication. Cox B-IN-1 (7a) demonstrates substantial potential as an inhibitor of the 3C protease from coxsackievirus[1].

Product Specifications

UNSPSC

12352005

Target

Enterovirus

Related Pathways

Anti-infection

Field of Research

Infection; Inflammation/Immunology

Smiles

CC1=C(SC(N/N=C2C(C=CC=C3)=C3C(/C\2=C/C4=CC(OC)=CC=C4OC)=N\NC5=NC(C)=C(/N=N/C6=CC=CC=C6)S5)=N1)/N=N/C7=CC=CC=C7

Molecular Formula

C38H32N10O2S2

Molecular Weight

724.86

References & Citations

[1]Thoraya A Farghaly, et al. Synthesis, characterization, molecular docking, pharmacokinetics, and molecular dynamics of new bis-thiazoles based on bis-thiosemicarbazone as anti-coxsackievirus. Sci Rep. 2024 Nov 26;14 (1) :29378.